Ensign Peak Advisors, Inc Immunic, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $55.3 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$7.34 - $10.25 $246,726 - $344,543
-33,614 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$8.05 - $13.29 $469,967 - $775,883
-58,381 Reduced 63.46%
33,614 $297,000
Q3 2020

Nov 12, 2020
BUY
$11.74 - $22.0 $1.08 Million - $2.02 Million
91,995 New
91,995 $1.71 Million

Others Institutions Holding IMUX

# of Institutions
75
Shares Held
55.8M
Call Options Held
100
Put Options Held
350K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $28.7M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email